ConductScience.org, home

Paper3876271

Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1.

Kuribayashi K and 3 others. Immunology, 1985. Cited by 9 papers, by iCite.

Cite this record

ConductScience Library. Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1. Papers, record 3876271. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/3876271

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effector mechanisms of syngeneic anti-tumour responses in mice. I. Establishment and characterization of an exogenous IL-2-independent cytotoxic T-lymphocyte line specific for radiation-induced leukaemia RL male 1.
PubMed
Journal
Immunology
PubMed
Year
1985
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
9
iCite
Relative citation ratio, by iCite
0.18
iCite
Revised in PubMed
2018-11-13
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Kuribayashi KK
2Keyaki AA
3Sakaguchi SS
4Masuda TT

Source PubMed

Download CSV of authors

Topics15

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Cell LineMajor topic
Leukemia, Radiation-InducedMajor topic
T-Lymphocytes, CytotoxicMajor topic
Animals
Antigens, Surface
Cytotoxicity, Immunologic
Female
Histocompatibility Antigens Class II
Interleukin-2
Lymphocyte Activation
Major Histocompatibility Complex
Male
Mice
Mice, Inbred Strains
Spleen

Source PubMed

Download CSV of topics

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
17042543The biochemistry, biology, and role of interleukin 2 in the induction of cytotoxic T cell and antibody-forming B cell responses.Immunol Rev1982https://conductscience.org/library/papers/7042543PubMed
26801833Which T cells cause graft rejection?Transplantation1982https://conductscience.org/library/papers/6801833PubMed
36213710Functional activity in vivo of effector T cell populations. I. Antitumor activity exhibited by allogeneic mixed leukocyte culture cells.J Immunol1982https://conductscience.org/library/papers/6213710PubMed
46184410Regulation of the immune response to tumor antigens. IX. In vitro Lyt-1+2- cell proliferative responses to cellbound or subcellular tumor antigen.J Immunol1983https://conductscience.org/library/papers/6184410PubMed
56983557Study on cellular events in postthymectomy autoimmune oophoritis in mice. I. Requirement of Lyt-1 effector cells for oocytes damage after adoptive transfer.J Exp Med1982https://conductscience.org/library/papers/6983557PubMed
66189937Expression of passively transferred immunity against an established tumor depends on generation of cytolytic T cells in recipient. Inhibition by suppressor T cells.J Exp Med1983https://conductscience.org/library/papers/6189937PubMed
76224401The in vitro generation of effector lymphocytes and their employment in tumor immunotherapy.Adv Cancer Res1983https://conductscience.org/library/papers/6224401PubMed
83876272Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system.Immunology1985https://conductscience.org/library/papers/3876272PubMed
914284941CYTOTOXIC TEST FOR DEMONSTRATION OF MOUSE ANTIBODY.Methods Med Res1964https://conductscience.org/library/papers/14284941PubMed
104727915Leukemia-associated transplantation antigens related to murine leukemia virus. The X.1 system: immune response controlled by a locus linked to H-2.J Exp Med1973https://conductscience.org/library/papers/4727915PubMed
111092799Functional subclasses of T lymphocytes bearing different Ly antigens. II. Cooperation between subclasses of Ly+ cells in the generation of killer activity.J Exp Med1975https://conductscience.org/library/papers/1092799PubMed
121084897Two functionally distinct anti-tumor effector cells isolated from primary murine sarcoma virus-induced tumors.J Immunol1976https://conductscience.org/library/papers/1084897PubMed
13830744Passive transfer of systemic tumor immunity with cells generated in vitro by a secondary immune response to a syngeneic rat gross virus-induced lymphoma.J Immunol1977https://conductscience.org/library/papers/830744PubMed
14326003Passive immunotherapy of cancer in animals and man.Adv Cancer Res1977https://conductscience.org/library/papers/326003PubMed
15301897Inflammatory cells in solid murine neoplasms. IV. Cytolytic T lymphocytes isolated from regressing or progressing Moloney sarcomas.J Immunol1977https://conductscience.org/library/papers/301897PubMed
16307029T cell growth factor: parameters of production and a quantitative microassay for activity.J Immunol1978https://conductscience.org/library/papers/307029PubMed
17308439Cloned T-cell lines with specific cytolytic activity.Curr Top Microbiol Immunol1978https://conductscience.org/library/papers/308439PubMed
1881780Cell-mediated anti-tumor response in the RLmale 1 system. I. T nature, H-2Dd involvement and antigenic specificity of the effector cells.Eur J Immunol1978https://conductscience.org/library/papers/81780PubMed
19309919
T-T-cell interactions during the vitro cytotoxic allograft responses. I. Soluble products from activated Lyl+ T cells trigger autonomously antigen-primed Ly23+ T cells to cell proliferation and cytolytic activity.
J Exp Med1978https://conductscience.org/library/papers/309919PubMed
2088050Cytotoxic T cells: Lyt phenotype and blocking of killing activity by Lyt antisera.Proc Natl Acad Sci U S A1979https://conductscience.org/library/papers/88050PubMed

See all 35 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 9 citations.

PMIDTitleJournalYearIn PapersSource
8205558Immunological characterization of tumor-rejection antigens on ultraviolet-light-induced tumors originating in the CB6F1 mouse.Cancer Immunol Immunother1994https://conductscience.org/library/papers/8205558PubMed
3876272Effector mechanisms of syngeneic anti-tumour responses in mice. II. Cytotoxic T lymphocytes mediate neutralization and rejection of radiation-induced leukaemia RL male 1 in the nude mouse system.Immunology1985https://conductscience.org/library/papers/3876272PubMed

Download CSV of cited by

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/3876271

GET https://conductscience.org/api/papers/v1/3876271/references?page=2